Top 10 developments in securities regulation for January 2026
On the 14th of January in 2026, the Securities and Exchange Commission (SEC) took legal action against Hong Wang, also...
Securities Fraud
uniQure N.V. Investors: Class Action Announcement from Kessler Topaz Meltzer & Check, LLP
A recent class action lawsuit has been initiated against uniQure N.V. by Kessler Topaz Meltzer & Check, LLP on behalf...
Oklahoma Department of Securities warns about scams aimed at senior citizens
The Oklahoma Department of Securities is taking action to address scams that target senior citizens. These scams often involve fraud...
Rick Perry pledges to spend as much as necessary for John Cornyn
Former Texas Governor Rick Perry emphasized his unwavering support for Senator John Cornyn in the upcoming Republican primary while speaking...
Deadline for becoming the lead plaintiff in securities fraud lawsuit against Kyndryl Holdings, Inc. (KD) is April 13, 2026.
Deadline to Lead in Securities Fraud Lawsuit Against Kyndryl Holdings, Inc. (KD) is April 13, 2026 - Contact Kaplan Fox...
Investors in RARE Can Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
Investor rights law firm Rosen Law Firm is notifying individuals who acquired Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between...
Investors in DOOR Can Take the Lead in Masonite International Corporation Securities Fraud Suit
DOOR Investors Get Chance to Take Lead in Masonite International Corporation Stock Fraud Lawsuit Investors in Masonite International Corporation have...
Investors in KD have chance to take lead in Kyndryl Holdings securities fraud case
Investors in Kyndryl Holdings, Inc. have the opportunity to take the lead in a securities fraud lawsuit against the company...
Deadline approaching: Shareholders of Klarna Group plc (KLAR) who have suffered losses encouraged to reach out…
A securities fraud class action lawsuit has been initiated on behalf of investors who purchased shares in Klarna Group plc...
Securities Fraud Class Action Filed Against uniQure N.V. Following FDA Approval Delay and 49% Stock Decline
A recent Securities Fraud Class Action against uniQure N.V. has resulted in significant losses for investors due to a delay...
Investors Can Take Lead in Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
Investors in Ultragenyx Pharmaceutical Inc. who sustained securities fraud are urged to consider their lawful options by the Rosen Law...
Investigation into Securities Fraud at Baidu, Inc. (BIDU) Ongoing
Investors who have suffered losses from investing in Baidu Inc. (BIDU) are encouraged to seek legal counsel from Glancy Prongay...